David S. Romeo

Array ( [id] => 6196633 [patent_doc_number] => 20110028391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'Use of GLP-1 Peptides' [patent_app_type] => utility [patent_app_number] => 12/905324 [patent_app_country] => US [patent_app_date] => 2010-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5383 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028391.pdf [firstpage_image] =>[orig_patent_app_number] => 12905324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6128220 [patent_doc_number] => 20110086906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'METHODS FOR TREATMENT OR PREVENTION OF DISEASES ASSOCIATED WITH FUNCTIONAL DISORDER OF REGULATORY T CELLS' [patent_app_type] => utility [patent_app_number] => 12/902389 [patent_app_country] => US [patent_app_date] => 2010-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17849 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086906.pdf [firstpage_image] =>[orig_patent_app_number] => 12902389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6017139 [patent_doc_number] => 20110224410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'Buffers for Controlling the pH of Bone Morphogenetic Proteins' [patent_app_type] => utility [patent_app_number] => 12/884414 [patent_app_country] => US [patent_app_date] => 2010-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8492 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224410.pdf [firstpage_image] =>[orig_patent_app_number] => 12884414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6096455 [patent_doc_number] => 20110003399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Tumor Necrosis Factor-Gamma' [patent_app_type] => utility [patent_app_number] => 12/879210 [patent_app_country] => US [patent_app_date] => 2010-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 122640 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003399.pdf [firstpage_image] =>[orig_patent_app_number] => 12879210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016487 [patent_doc_number] => 20110224138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'METHODS FOR TREATING PAIN INDUCED BY INJURIES AND DISEASES OF AN ARTICULAR JOINT' [patent_app_type] => utility [patent_app_number] => 12/878716 [patent_app_country] => US [patent_app_date] => 2010-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8895 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224138.pdf [firstpage_image] =>[orig_patent_app_number] => 12878716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6152083 [patent_doc_number] => 20110155605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'Apo-2 ligand' [patent_app_type] => utility [patent_app_number] => 12/806496 [patent_app_country] => US [patent_app_date] => 2010-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21018 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20110155605.pdf [firstpage_image] =>[orig_patent_app_number] => 12806496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8559901 [patent_doc_number] => 08333963 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-18 [patent_title] => 'Method of inhibiting osteoclast activity' [patent_app_type] => utility [patent_app_number] => 12/850368 [patent_app_country] => US [patent_app_date] => 2010-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5154 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12850368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007073 [patent_doc_number] => 20110059104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'Apo-2L receptor agonist and CPT-11 synergism' [patent_app_type] => utility [patent_app_number] => 12/804789 [patent_app_country] => US [patent_app_date] => 2010-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 28953 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059104.pdf [firstpage_image] =>[orig_patent_app_number] => 12804789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8533364 [patent_doc_number] => 08309518 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-13 [patent_title] => 'Drug delivery matrices to enhance wound healing' [patent_app_type] => utility [patent_app_number] => 12/845354 [patent_app_country] => US [patent_app_date] => 2010-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 11351 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12845354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8211168 [patent_doc_number] => 20120129778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'LIGAND THAT BIND TGF-BETA RECEPTOR RII' [patent_app_type] => utility [patent_app_number] => 13/387376 [patent_app_country] => US [patent_app_date] => 2010-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 24448 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20120129778.pdf [firstpage_image] =>[orig_patent_app_number] => 13387376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4634255 [patent_doc_number] => 08012704 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-06 [patent_title] => 'Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use' [patent_app_type] => utility [patent_app_number] => 12/803779 [patent_app_country] => US [patent_app_date] => 2010-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 12361 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/012/08012704.pdf [firstpage_image] =>[orig_patent_app_number] => 12803779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6582053 [patent_doc_number] => 20100291125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'ETA-1 GENE AND METHODS FOR USE' [patent_app_type] => utility [patent_app_number] => 12/822589 [patent_app_country] => US [patent_app_date] => 2010-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 26345 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291125.pdf [firstpage_image] =>[orig_patent_app_number] => 12822589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6273088 [patent_doc_number] => 20100255498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'METHODS FOR IDENTIFYING COMPOUNDS THAT REGULATE BETA-ARRESTIN SIGNALING COMPLEXES' [patent_app_type] => utility [patent_app_number] => 12/816764 [patent_app_country] => US [patent_app_date] => 2010-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2525 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20100255498.pdf [firstpage_image] =>[orig_patent_app_number] => 12816764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6202857 [patent_doc_number] => 20110065643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'Clusterin Pharmaceuticals and Treatment Methods Using the Same' [patent_app_type] => utility [patent_app_number] => 12/814349 [patent_app_country] => US [patent_app_date] => 2010-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16200 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065643.pdf [firstpage_image] =>[orig_patent_app_number] => 12814349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6186195 [patent_doc_number] => 20110124554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'Fibrosuppressant Biotherapeutics' [patent_app_type] => utility [patent_app_number] => 12/789304 [patent_app_country] => US [patent_app_date] => 2010-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 11240 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124554.pdf [firstpage_image] =>[orig_patent_app_number] => 12789304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10121453 [patent_doc_number] => 09155801 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-13 [patent_title] => 'Amino acid sequences which enhance peptide conjugate solubility' [patent_app_type] => utility [patent_app_number] => 13/322914 [patent_app_country] => US [patent_app_date] => 2010-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19986 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13322914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7699970 [patent_doc_number] => 20110226620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'Highly Homogeneous Molecular Markers for Electrophoresis' [patent_app_type] => utility [patent_app_number] => 12/786406 [patent_app_country] => US [patent_app_date] => 2010-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19091 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20110226620.pdf [firstpage_image] =>[orig_patent_app_number] => 12786406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6071196 [patent_doc_number] => 20110046047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'Bone Morphogenetic Proteins for Appetite Control' [patent_app_type] => utility [patent_app_number] => 12/784228 [patent_app_country] => US [patent_app_date] => 2010-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15687 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046047.pdf [firstpage_image] =>[orig_patent_app_number] => 12784228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8041345 [patent_doc_number] => 20120070408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING LUPUS' [patent_app_type] => utility [patent_app_number] => 13/320001 [patent_app_country] => US [patent_app_date] => 2010-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 6156 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20120070408.pdf [firstpage_image] =>[orig_patent_app_number] => 13320001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134252 [patent_doc_number] => 20110008248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Peptide Antagonists of TGF-Beta Family Members and Therapeutic Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/768145 [patent_app_country] => US [patent_app_date] => 2010-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12550 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008248.pdf [firstpage_image] =>[orig_patent_app_number] => 12768145 [rel_patent_id] =>[rel_patent_doc_number] =>)